NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
64678-012-02 | 64678-012 | HUMAN PRESCRIPTION DRUG | Tembexa | Brincidofovir | SUSPENSION | ORAL | 20220420 | N/A | NDA | NDA214460 | Emergent BioDefense Operations Lansing LLC | BRINCIDOFOVIR | 10 mg/mL | 65 mL in 1 BOTTLE (64678-012-02) |
64678-012-01 | 64678-012 | HUMAN PRESCRIPTION DRUG | Tembexa | Brincidofovir | SUSPENSION | ORAL | 20220420 | N/A | NDA | NDA214460 | Emergent BioDefense Operations Lansing LLC | BRINCIDOFOVIR | 10 mg/mL | 65 mL in 1 BOTTLE (64678-012-01) |
79622-012-70 | 79622-012 | HUMAN PRESCRIPTION DRUG | Tembexa | Brincidofovir | SUSPENSION | ORAL | 20220420 | N/A | NDA | NDA214460 | Chimerix, Inc. | BRINCIDOFOVIR | 10 mg/mL | 65 mL in 1 BOTTLE (79622-012-70) |
79622-012-65 | 79622-012 | HUMAN PRESCRIPTION DRUG | Tembexa | Brincidofovir | SUSPENSION | ORAL | 20220420 | N/A | NDA | NDA214460 | Chimerix, Inc. | BRINCIDOFOVIR | 10 mg/mL | 65 mL in 1 BOTTLE (79622-012-65) |